These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3524471)

  • 1. Effect of intralesional alpha 2-interferon on actinic keratoses.
    Edwards L; Levine N; Weidner M; Piepkorn M; Smiles K
    Arch Dermatol; 1986 Jul; 122(7):779-82. PubMed ID: 3524471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of topical interferon alpha 2b on actinic keratoses.
    Edwards L; Levine N; Smiles KA
    J Dermatol Surg Oncol; 1990 May; 16(5):446-9. PubMed ID: 2341658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant interferon alfa-2b in plaque-phase mycosis fungoides. Intralesional and low-dose intramuscular therapy.
    Vonderheid EC; Thompson R; Smiles KA; Lattanand A
    Arch Dermatol; 1987 Jun; 123(6):757-63. PubMed ID: 3579357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intralesional recombinant alpha-2 interferon for the treatment of patients with condyloma acuminatum or verruca plantaris.
    Vance JC; Bart BJ; Hansen RC; Reichman RC; McEwen C; Hatch KD; Berman B; Tanner DJ
    Arch Dermatol; 1986 Mar; 122(3):272-7. PubMed ID: 3954392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of recurrent common warts with one low dose of intralesional natural human leukocyte interferon alpha.
    Pueyo S; Criscuolo M; Davidovich C; Zorzópulos J; Pesce A; Díaz A
    J Biol Regul Homeost Agents; 1990; 4(2):47-50. PubMed ID: 2260502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventative effect of etretinate therapy on multiple actinic keratoses.
    Watson AB
    Cancer Detect Prev; 1986; 9(1-2):161-5. PubMed ID: 3524840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.
    Ozer H; Gavigan M; O'Malley J; Thompson D; Dadey B; Nussbaum-Blumenson A; Snider C; Rudnick S; Ferraresi R; Norred S
    J Biol Response Mod; 1983; 2(6):499-515. PubMed ID: 6607323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant interferon alpha-2 (INTRON A) in a phase II study of renal cell carcinoma.
    Kempf RA; Grunberg SM; Daniels JR; Skinner DG; Venturi CL; Spiegel R; Neri R; Greiner JM; Rudnick S; Mitchell MS
    J Biol Response Mod; 1986 Feb; 5(1):27-35. PubMed ID: 3958753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of neoplastic skin lesions with intralesional interferon.
    Wickramasinghe L; Hindson TC; Wacks H
    J Am Acad Dermatol; 1989 Jan; 20(1):71-4. PubMed ID: 2913082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical application of human fibroblast interferon (IFN) in cutaneous leishmaniasis.
    Trau H; Schewach-Millet M; Shoham J; Doerner T; Shor R; Passwell JH
    Isr J Med Sci; 1987 Nov; 23(11):1125-7. PubMed ID: 3325468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Phase I study of human lymphoblastoid alpha-interferon on malignant tumor].
    Furue H
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):977-83. PubMed ID: 3963861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recombinant interferon alpha-2 (Sch 30500) in patients with head and neck cancer].
    Miyake H; Horiuchi M; Togawa K; Kawamoto K; Kaneko T; Inuyama Y; Honda Y; Baba S; Matsunaga T; Ishikawa T
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1651-5. PubMed ID: 3896156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phase II studies of interferon alpha-2 Sch 30500 in advanced gastrointestinal carcinoma].
    Furue H
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1625-9. PubMed ID: 3896154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Behçet disease and exogenous interferon. A successful treatment study using recombinant alpha-A-IFN].
    Stadler R; Bratzke B; Baumann I
    Hautarzt; 1987 Feb; 38(2):97-100. PubMed ID: 3570783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sun-related factors, betapapillomavirus, and actinic keratoses: a prospective study.
    McBride P; Neale R; Pandeya N; Green A
    Arch Dermatol; 2007 Jul; 143(7):862-8. PubMed ID: 17638729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical phase II trial of recombinant DNA interferon (interferon alpha 2b) in patients with metastatic malignant melanoma.
    Dorval T; Palangie T; Jouve M; Garcia-Giralt E; Israel L; Falcoff E; Schwab D; Pouillart P
    Cancer; 1986 Jul; 58(2):215-8. PubMed ID: 3719515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in biopsy techniques of actinic keratoses by plastic surgeons and dermatologists: a histologically controlled pilot study.
    Sellheyer K; Bergfeld WF
    Arch Dermatol; 2006 Apr; 142(4):455-9. PubMed ID: 16618864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interferon (IFN) therapy (recombinant IFN-alpha-2C or recombinant IFN-gamma) in metastasized hypernephroma].
    Kuzmits R; Scheithauer W; Ludwig H; Flener R
    Acta Med Austriaca; 1985; 12(5):129-34. PubMed ID: 3938590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety assessment of 0.5% and 1% colchicine cream in the treatment of actinic keratoses.
    Akar A; Bülent Taştan H; Erbil H; Arca E; Kurumlu Z; Gür AR
    J Dermatolog Treat; 2001 Dec; 12(4):199-203. PubMed ID: 12241628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of two sequential phase II studies of interleukin-2 (IL2) in metastatic renal cell carcinoma and melanoma: high-dose continuous intravenous IL2 infusion and subcutaneous IL2 administration in combination with alpha interferon.
    Hidalgo OF; Aramendía JM; Alonso G; Foncillas JG; Brugarolas A
    Rev Med Univ Navarra; 1996; 40(3):6-12. PubMed ID: 9499820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.